Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Momenta Phama (MNTA) Announces 7.25M Common Offering
May 18, 2015 4:03 PM EDTMomenta Phama (NASDAQ: MNTA) announced that it is commencing an underwritten registered public offering of 7,250,000 shares of its common stock. Momenta expects to grant the underwriters of the offering an option to purchase up to an additional 1,087,500 shares of its common stock,... More
